Nubratori, Inc

FDA Regulatory Profile

Nubratori, Inc appears in FDA public data with 1 recall, 0 510(k) clearances, 4 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0392-2025, Class II) was initiated on April 15, 2025.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
4
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0392-2025Class IIDexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL SingApril 15, 2025